Concepedia

Carol O’Brien

CO

Statistics

Publications

27

Citations

3.5K

H-Index

23

Active since

2005

Affiliations

Trinity College Dublin(Current)

Ollscoil na Gaillimhe – University of Galway

Translational Research in Oncology

University of California, San Francisco

RTI International

Carol O’Brien is an author at Trinity College Dublin specializing in medicine, radiation oncology, and tumor biology.

ORCID

Top concepts

Publications per year

2005–2022

27

Publications

27

<i>In vivo</i> Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models

Klaus P. Hoeflich, Carol O’Brien, Zachary Boyd et al. · Clinical Cancer Research · 2009 · 470 citations

De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability

Siobhan McCarthy, Jesse Gillis, Melissa Kramer et al. · Molecular Psychiatry · 2014 · 360 citations · Full text

, , +11

TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer

Susanna Stinson, Mark R. Lackner, Alex Adai et al. · Science Signaling · 2011 · 312 citations

, , +13

Predictive Biomarkers of Sensitivity to the Phosphatidylinositol 3′ Kinase Inhibitor GDC-0941 in Breast Cancer Preclinical Models

Carol O’Brien, Jeffrey J. Wallin, Deepak Sampath et al. · Clinical Cancer Research · 2010 · 257 citations · Full text

GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway

Jeffrey J. Wallin, Kyle A. Edgar, Jane Guan et al. · Molecular Cancer Therapeutics · 2011 · 226 citations

, , +20

1–5 of 27